Clinical Trial: A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Grippe
Study Type: INTERVENTIONAL
Official Title: A PHASE 1, RANDOMIZED, OBSERVER-BLIND, DOSE-RANGING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINE CANDIDATES AGAINST PANDEMIC INFLUENZA IN HEALTHY INDIVIDUALS
Brief Summary:
The purpose of this study is to learn about the safety and effects of the study vaccine for the possible prevention of influenza.Influenza is a disease that can spread easily from one person to another and cause body aches, fever, cough, and other symptoms.The study vaccine is called Pandemic Influenza modRNA (pdmFlu) Vaccine.This study is seeking for participants who are:between the age of 18 to 49 years old.willing and able to follow with all scheduled visits, treatment plan, laboratory tests, lifestyle changes,…
Read more